An ELISA detection method based on aggregation-induced emission ratio fluorescent probe

Through the ratio fluorescence of red and green AIE fluorescence microspheres, the problems of poor enzyme stability and background interference in the ELISA method are solved, and high sensitivity and accuracy detection is achieved, which is suitable for quantitative detection of a variety of disease markers and pathogens.

CN114778825BActive Publication Date: 2024-11-22NANCHANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210244161.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-03-11
Publication Date
2024-11-22
Estimated Expiration
2042-03-11

AI Technical Summary

Technical Problem

In practical applications, the ELISA method has problems such as poor enzyme stability and background signal interference, resulting in low detection sensitivity, especially the difficulty in qualitative or semi-quantitative visual inspection of naked eyes, and traditional methods rely on HRP enzyme catalyzed color-development single signal response, and the quantitative results are accurate. Sex and sensitivity are affected by a variety of irrelevant parameters.

Method used

Using red and green AIE fluorescent microsphere ratio fluorescence technology, reduce external interference through self-calibration, and eliminate traditional enzyme-label secondary antibody and catalytic color development steps. Use red AIE fluorescent microspheres to conjugate target antigen and green AIE fluorescent microspheres. Coupled with biotin or digoxin antibody, quantitative detection of the target is achieved by calculating the R/G ratio.

Benefits of technology

It improves the sensitivity and accuracy of detection, reduces background interference, simplifies the operation process, enhances the reliability of naked-eye identification results, and is suitable for the detection of a variety of disease markers and pathogens.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114778825B_ABST
    Figure CN114778825B_ABST
Patent Text Reader

Abstract

The present invention discloses an ELISA detection method based on an aggregation-induced emission ratio fluorescent probe, wherein the ratio fluorescent probe includes red and green AIE fluorescent microspheres. The red AIE microspheres are coupled to antigens, the green fluorescent microspheres are coupled to biotin or digoxigenin antibodies, and the ELISA coated antibodies and streptavidin or digoxigenin complete antigens. In the ELISA reaction system, the antigen coupled to the red AIE fluorescent microspheres is combined with the antibodies on the ELISA, and red fluorescence is emitted at 610nm, and the reading value is recorded as R; the biotin coupled to the green AIE fluorescent microspheres is combined with streptavidin on the ELISA plate or the digoxigenin antibodies are combined with the digoxigenin complete antigens, and green fluorescence is emitted at 501nm, and the reading value is recorded as G. The concentration of the target can be quantitatively detected by calculating the value of R / G. The present invention reduces external interference to a minimum through self-calibration, and at the same time eliminates the use of enzyme-labeled secondary antibodies to catalyze color development instability and the cumbersome steps of ELISA itself, providing new technologies and new ideas for solving the problems of cumbersome operation and easy background interference of traditional ELISA methods.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of enzyme-linked immunosorbent assay, and in particular to an ELISA detection method based on aggregation-induced luminescence ratio fluorescent probe, the technical principle of which is a direct competition method or a double antibody sandwich method. Background Art

[0002] ELISA has high sensitivity, strong specificity, low cost, simple equipment, and does not require professional personnel to operate. It can be used for on-site rapid detection in laboratories, enterprises, other departments, etc. Although many ELISA methods have been developed and commercialized so far, there are still some challenges in the actual application of ELISA. First, the visual inspection of ELISA is based on the change of color intensity or brightness, so it is difficult to perform qualitative or semi-quantitative analysis when the color is weak during the detection process, especially for untrained inspectors or patients. Second, most ELISAs rely on a single signal response of HRP enzyme-catalyzed RAIE color development, and the accuracy and sensitivity of the quantitative results are affected by many parameters unrelated to the analyte, such as enzyme stability, photobleaching, and light scattering. Therefore, solving these technical problems to promote the widespread application of ELISA has become a hot area of ​​research in recent years.

[0003] Ratiometric fluorescence technology relies on the intensity ratio of two or more emission bands to achieve quantitative detection of targets and is now widely used in the design of fluorescence sensors. Unlike a single fluorescent signal, a ratiometric fluorescence system can minimize external interference through self-calibration to improve detection sensitivity. In addition, a ratiometric fluorescence system can also output different colors with typical hues to enhance visual recognition. Compared with simple color intensity, changes in hue can better read the results with the naked eye. In addition, as the intensity of the three primary colors (red-green-blue, RGB) changes, the hue will also change. Therefore, the signal intensity ratio of different colors (such as R / G) can be used to quantify the concentration of the target. Summary of the invention

[0004] The present invention aims to address the current defects of the existing ELISA in the actual operation process, such as poor enzyme stability and easy background signal interference, which leads to low detection sensitivity. The red and green AIE fluorescent microsphere ratio fluorescence technology is used to minimize external interference through self-calibration. At the same time, the use of traditional enzyme-labeled secondary antibodies and the unstable and cumbersome steps of catalytic color development can be omitted, providing new technology and new ideas for solving the problems of cumbersome operation and easy background interference of traditional ELISA methods.

[0005] To achieve the above object, the technical solution adopted by the present invention is:

[0006] An ELISA detection method based on an aggregation-induced emission ratio fluorescent probe, wherein the ratio fluorescent probe includes two colors of AIE fluorescent microspheres, including red AIE fluorescent microspheres RAIENPs and green AIE fluorescent microspheres GAIENPs, and the RAIENPs and GAIENPs have the same excitation wavelength of 360 nm, and the emission wavelengths are 501 nm and 610 nm, respectively, and the emission peaks do not overlap. The particle sizes of the two colors of fluorescent microspheres are 150 nm±5% and 350 nm±5%. The RAIENPs are coupled to the antigen RAIENPs@Antigen, and the GAIENPs are coupled to biotin or digoxin antibodies (GAIENPs@Bio or GAIENPs@DigmAbs). The ELISA is coated with antibodies and streptavidin (SA) or digoxin whole antigen (Dig-BSA). The RAIENPs@Antigen binds to the antibody on the ELISA plate, emitting red fluorescence at 610 nm, and the reading is recorded as R; the GAIENPs@Bio binds to the SA on the ELISA plate or the GAIENPs@DigmAbs binds to Dig-BSA, emitting green fluorescence at 501 nm, and the reading is recorded as G. The concentration of the target can be quantitatively detected by calculating the R / G value.

[0007] The synthesis steps of the two AIE fluorescent microspheres are as follows:

[0008] The two color AIE molecules RAIE and GAIE were dissolved in tetrahydrofuran solution respectively as liquid A, and the polystyrene microspheres with carboxyl surface were dispersed in sodium dodecyl sulfate aqueous solution as liquid B. First, liquid A was added to acetone and mixed, and then liquid B was added while stirring. The acetone was evaporated to a small amount under magnetic stirring at room temperature for 10-20 h, and the product was obtained by centrifugation and washed with ultrapure water. The obtained AIE fluorescent microspheres RAIENPs and GAIENPs were suspended and dispersed in ultrapure water for later use.

[0009] Furthermore, the particle sizes of polystyrene microspheres are 150 nm and 350 nm, and the structural formula of the red AIE molecule RAIE is:

[0010] ,

[0011] The molecular formula of the green AIE molecule GAIE is:

[0012] ,

[0013] Furthermore, the mass ratio of polystyrene microspheres to AIE molecules is 1:0.5-1.5, and the volume ratio of liquid B to acetone is 1:3-5.

[0014] The preparation steps of the two fluorescent probes are as follows:

[0015] a) Red AIE fluorescent microspheres coupled to antigens: Add the red aggregation-induced emission fluorescent microspheres RAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add antigen or labeled antibody, and after electrostatic adsorption for 15 min, add EDC to activate the carboxyl groups on the surface of the microspheres, then add a protein blocking agent to block the carboxyl groups on the surface of the microspheres that are not bound to the antigen or labeled antibody. After incubation, centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare a probe;

[0016] b) Green AIE fluorescent microspheres coupled with biotin or digoxigenin antibody: Add the green aggregation-induced emission fluorescent microspheres GAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add biotin or digoxigenin antibody. After electrostatic adsorption for 15 minutes, add EDC to activate the carboxyl groups on the surface of the microspheres. Then add a protein blocking agent to block the carboxyl groups on the surface of the microspheres that are not bound to the antigen. After incubation, centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare a probe.

[0017] Furthermore, the pH of the PB buffer is 5.5-8.0.

[0018] Furthermore, the final concentration after adding the antigen or labeled antibody is 1 to 100 μg / mL, the final concentration after adding ethyl-N,N-dimethylpropylcarbodiimide is 0.01 to 1 mg / mL, and the final concentration of the blocking agent after adding the blocking agent is 1.5 to 3%, and the blocking agent is selected from any one of casein, bovine serum albumin, ovalbumin, and skim milk.

[0019] Furthermore, the centrifugal speed is 12000-14000 rpm, and the time is 10-30 min.

[0020] Furthermore, the precipitate after centrifugation is reconstituted with an AIE reconstitution solution to 1 to 1 / 10 times the initial volume to prepare a probe, which is then stored at 4°C for future use.

[0021] The ELISA test steps are as follows:

[0022] a) Coating: dilute the target antibody and streptavidin or digoxigenin complete antigen to 1 μg / mL with CBS 9.6 and add 100 μL to each well. Coat the plate overnight at 4°C and wash the plate three times with PBST.

[0023] b) Blocking: Block each well with 300 μL 0.2% gelatin CBS9.6 at 37°C for 2 h and then wash the plate three times with PBST;

[0024] c) Capture target antigen: 50 μL PBS 7.4 per negative well, 50 μL target antigen per positive well, then add 50 μL red AIE microsphere-coupled antigen and green AIE microsphere-coupled biotin or digoxigenin antibody, react at 37°C for 30 min, and wash the plate three times with PBST.

[0025] d) Reading value: The green AIE fluorescent microspheres coupled with biotin bind to the coated streptavidin (digoxigenin antibody and digoxigenin antigen), emitting green fluorescence at 501 nm, and the reading value is recorded as G; after adding the analyte and the target antigen (labeled antibody) coupled with the red AIE fluorescent microspheres, the antigen and antibody specifically bind to each other, emitting red fluorescence at 610 nm, and the reading value is recorded as R. For direct competitive ELISA, as the number of targets increases, the lower the red fluorescence R value, the lower the R / G value; for double antibody sandwich ELISA, as the number of targets increases, the higher the red fluorescence R value, the higher the R / G value.

[0026] The direct competitive ELISA of the present invention is suitable for the detection of mycotoxins, and the disease mycotoxins include: aflatoxins such as aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, aflatoxin M1, aflatoxin M2, aflatoxin GM, aflatoxin P1, aflatoxin Q1, ochratoxin A, trichothecenes, zearalenone, T2 toxin, deoxynivalenol, and fumonisins including fumonisin B1, fumonisin B2, and fumonisin B3.

[0027] The double antibody sandwich ELISA of the present invention is suitable for the detection of disease-related markers, including: tumor markers such as carcinoembryonic antigen, prostate-specific antigen, alpha-fetoprotein; inflammatory markers such as C-reactive protein, procalcitonin, interleukin-6; myocardial markers such as troponin, myoglobin, N-terminal atrial natriuretic peptide and N-terminal brain natriuretic peptide; infectious disease markers such as novel coronavirus antigens and antibodies, HIV antigens and antibodies, Ebola virus antigens and antibodies, Middle East respiratory syndrome coronavirus antigens and antibodies, hepatitis B virus-related antigens and antibodies; pathogens such as viruses, pathogenic bacteria, etc. Sample processing can be carried out according to conventional processing methods.

[0028] Compared with the prior art, the present invention has the following beneficial effects:

[0029] The present invention is based on the traditional ELISA, and the ELISA plate is coated with antibodies and streptavidin or digoxigenin antibody, the red AIE microspheres are coupled with the target antigen or labeled antibody, and the green AIE fluorescent microspheres are coupled with biotin or digoxigenin labeled antibody. After the test object and the target antigen (labeled antibody) coupled with the red AIE fluorescent microspheres are added, red fluorescence is emitted at 610 nm, and the reading value is recorded as R; the green AIE fluorescent microspheres are coupled with biotin and the coated streptavidin (digoxigenin antibody and digoxigenin antigen) and emit green fluorescence at 501 nm, and the reading value is recorded as G. The direct competitive ELISA adopts the biotin-streptavidin system. As the number of targets increases, the lower the red fluorescence R value is, the lower the R / G value is; the double antibody sandwich ELISA adopts the digoxigenin-digoxigenin antibody system. As the number of targets increases, the higher the red fluorescence R value is, the higher the R / G value is. The present invention is based on the ratio fluorescence technology of red and green AIE fluorescent microspheres, which can minimize external interference through self-calibration. At the same time, it can eliminate the unstable color development catalyzed by enzyme-labeled secondary antibodies and the cumbersome steps of ELISA itself, and provide new technologies and new ideas for solving the problems of traditional ELISA methods, such as cumbersome operation and prone to background interference. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 1(a) is the principle diagram of direct competitive ELISA; 1(b) is the principle of double antibody sandwich ELISA. DETAILED DESCRIPTION

[0031] The specific implementation of the present invention will be described in detail below. In order to avoid too many unnecessary details, the well-known structures or functions will not be described in detail in the following embodiments.

[0032] Unless otherwise defined, technical and scientific terms used in the following examples have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0033] The test reagents and consumables used in the following examples are all conventional biochemical reagents unless otherwise specified; the experimental methods are all conventional methods unless otherwise specified. Example 1

[0034] A direct competitive ELISA based on aggregation-induced emission ratio fluorescence probe to detect AFB1, the principle is as follows Figure 1 (a) shown.

[0035] The ratio fluorescent probe used in this embodiment includes two colors of AIE fluorescent microspheres, including red AIE fluorescent microspheres RAIENPs and green AIE fluorescent microspheres GAIENPs, and the RAIENPs and GAIENPs have the same excitation wavelength of 360 nm, and the emission wavelengths are 501 nm and 610 nm, respectively, and the emission peaks do not overlap. The particle size of the two color fluorescent microspheres is 150 nm ± 5%. The RAIENPs are coupled to AFB1 (RAIENPs@AFB1), and the GAIENPs are coupled to biotin (GAIENPs@Bio). The ELISA is coated with antibodies and streptavidin. The RAIENPs@AFB1 binds to the AFB1 antibody on the ELISA, emits red fluorescence at 610 nm, and the reading is recorded as R; the GAIENPs@Bio binds to the SA on the ELISA plate, emits green fluorescence at 501 nm, and the reading is recorded as G. The AFB1 concentration can be quantitatively detected by calculating the value of R / G.

[0036] The specific plan is as follows:

[0037] 1. Synthesis of two AIE fluorescent microspheres

[0038] The two color AIE molecules RAIE and GAIE were dissolved in tetrahydrofuran solution respectively as liquid A, and the polystyrene microspheres with carboxyl surface were dispersed in sodium dodecyl sulfate aqueous solution as liquid B. First, liquid A was added to acetone and mixed, and then liquid B was added while stirring. The acetone was evaporated to a small amount under magnetic stirring at room temperature for 10-20 h, and the product was obtained by centrifugation and washed with ultrapure water. The obtained AIE fluorescent microspheres RAIENPs and GAIENPs were suspended and dispersed in ultrapure water for later use.

[0039] 2. Preparation of two fluorescent probes:

[0040] 1. Red AIE fluorescent microspheres coupled to antigens: Add the red aggregation-induced emission fluorescent microspheres RAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add AFB1 antigen, and after electrostatic adsorption for 15 min, add EDC to activate the carboxyl groups on the surface of the microspheres, then add a protein blocking agent to block the carboxyl groups on the surface of the microspheres that are not bound to the AFB1 antigen. After incubation, centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare a probe;

[0041] 2. Green AIE fluorescent microspheres coupled to biotin: Add the green aggregation-induced emission fluorescent microspheres GAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add BSA, and after electrostatic adsorption for 15 min, add EDC to activate the carboxyl groups on the surface of the microspheres, then add biotin, and after electrostatic adsorption for 15 min, add EDC to activate the carboxyl groups on biotin. After incubation, centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare a probe.

[0042] 3. ELISA test

[0043] 1. Coating: dilute AFB1 antibody and streptavidin to 1 μg / mL with CBS 9.6, add 100 μL to each well, coat the plate overnight at 4°C, and wash the plate three times with PBST; 2. Blocking: block each well with 300 μL 0.2% gelatin CBS 9.6 at 37°C for 2 h, and wash the plate three times with PBST; 3. Capture AFB1: add 50 μL PBS 7.4 to each well for negative and 50 μL AFB1 standard to each well for positive, then add 50 μL RAIENPs@AFB1 probe and GAIENPs@Bio probe, react at 37°C for 30 min, and wash the plate three times with PBST. 4. Reading value: GAIENPs@Bio binds to the coated SA and emits green fluorescence at 501 nm, which is recorded as G. After adding AFB1 and RAIENPs@AFB1, the two directly compete for the AFB1 antibody. After three washes, RAIENPs@AFB1 binds to the antibody and emits red fluorescence at 610 nm, which is recorded as R. As the amount of AFB1 increases, the red fluorescence R value decreases, and the R / G value decreases. Example 2

[0044] A double antibody sandwich ELISA based on aggregation-induced emission ratio fluorescent probe for detecting hepatitis B virus, the principle is as follows Figure 1 (b) shown.

[0045] The ratio fluorescent probe used in this embodiment includes two colors of AIE fluorescent microspheres, including red AIE fluorescent microspheres RAIENPs and green AIE fluorescent microspheres GAIENPs, and the RAIENPs and GAIENPs have the same excitation wavelength of 360 nm, emission wavelengths of 501 nm and 610 nm, respectively, and no overlap in emission peaks. The particle size of the two color fluorescent microspheres is 350 nm ± 5%. The RAIENPs are coupled to hepatitis B virus (HBV) labeled antibodies (RAIENPs@HBV mAbs), and GAIENPs are coupled to digoxin antibodies GAIENPs@Dig mAbs. The ELISA is coated with hepatitis B virus coated antibodies and digoxin complete antigens. The RAIENPs@HBV mAbs formed a sandwich structure with the HBV standard and the HBV-coated antibody on the ELISA plate, emitting red fluorescence at 610 nm, and the reading was recorded as R; the GAIENPs@Dig mAbs combined with the Dig-BSA on the ELISA plate, emitting green fluorescence at 501 nm, and the reading was recorded as G. The AFB1 concentration can be quantitatively detected by calculating the R / G value. As the number of HBV increases, the red fluorescence R value increases, and the R / G value increases.

[0046] The specific plan is as follows:

[0047] 1. Synthesis of two AIE fluorescent microspheres

[0048] The two color AIE molecules RAIE and GAIE were dissolved in tetrahydrofuran solution respectively as liquid A, and the polystyrene microspheres with carboxyl surface were dispersed in sodium dodecyl sulfate aqueous solution as liquid B. First, liquid A was added to acetone and mixed, and then liquid B was added while stirring. The acetone was evaporated to a small amount under magnetic stirring at room temperature for 10-20 h, and the product was obtained by centrifugation and washed with ultrapure water. The obtained AIE fluorescent microspheres RAIENPs and GAIENPs were suspended and dispersed in ultrapure water for later use.

[0049] 2. Preparation of two fluorescent probes:

[0050] 1. Red AIE fluorescent microspheres coupled to antibodies: Add the red aggregation-induced emission fluorescent microspheres RAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add HBV labeled antibodies, add EDC to activate the carboxyl groups on the surface of the microspheres after electrostatic adsorption for 15 min, then add protein blocking agent to block the carboxyl groups on the surface of the microspheres that are not bound to the AFB1 antigen, incubate and centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare the probe;

[0051] 2. Green AIE fluorescent microspheres coupled to digoxigenin-labeled antibodies: Add the green aggregation-induced emission fluorescent microspheres GAIENPs prepared in step (1) to 0.5-5 mL PB buffer, then add digoxigenin antibody. After electrostatic adsorption for 15 min, add EDC to activate the carboxyl groups on the surface of the microspheres. Then add a protein blocking agent to block the carboxyl groups on the surface of the microspheres that are not bound to the antigen. After incubation, centrifuge, discard the supernatant, and re-dissolve the precipitate with a re-solution to prepare a probe.

[0052] 3. ELISA test

[0053] 1. Coating: dilute HBV coating antibody and Dig-BSA to 1 μg / mL with CBS 9.6, add 100 μL to each well, coat the plate overnight at 4°C, and wash the plate three times with PBST; 2. Blocking: block each well with 300 μL 0.2% gelatin CBS 9.6 at 37°C for 2 h, and wash the plate three times with PBST; 3. Sandwiching: add 50 μL PBS 7.4 to each negative well and 50 μL HBV standard to each positive well, then add 50 μL RAIENPs@HBV mAbs probe and GAIENPs@Dig mAbs probe, react at 37°C for 30 min, and wash the plate three times with PBST. 4. Reading value: RAIENPs@HBV mAbs form a sandwich structure with HBV standard and HBV coated antibody on ELISA, emitting red fluorescence at 610 nm, and the reading value is recorded as R; the GAIENPs@Dig mAbs binds to Dig-BSA on the ELISA plate, emitting green fluorescence at 501 nm, and the reading value is recorded as G. The AFB1 concentration can be quantitatively detected by calculating the R / G value. As the number of HBV increases, the red fluorescence R value increases, and the R / G value increases.

Claims

1. An ELISA detection method based on aggregation-induced emission ratio fluorescent probe, characterized in that: The ratio fluorescent probe includes a probe prepared from two colors of AIE fluorescent microspheres, namely, red AIE fluorescent microspheres RAIENPs and green AIE fluorescent microspheres GAIENPs; the excitation wavelengths of the RAIENPs and GAIENPs are both 360 nm, and the emission wavelengths are 501 nm and 610 nm, respectively, and the emission peaks do not overlap; The ELISA detection method steps are: The RAIENPs are coupled with antigens RAIENPs@Antigen or labeled antibodies RAIENPs@HBV mAbs, the GAIENPs are coupled with biotin or digoxin antibodies GAIENPs@Bio or GAIENPs@DigmAbs, and the ELISA is coated with antibodies and streptavidin SA or digoxin whole antigen Dig-BSA; The RAIENPs@Antigen or RAIENPs@HBV mAbs bind to the antibody on the ELISA and emit red fluorescence at 610 nm, and the reading is recorded as R; The GAIENPs@Bio binds to SA on the ELISA plate or the GAIENPs@DigmAbs binds to Dig-BSA, emitting green fluorescence at 501 nm, and the reading is recorded as G; The concentration of the target substance is quantitatively detected by calculating the R / G value; The structural formula of the red AIE molecule RAIE used to prepare red AIE fluorescent microspheres is: The molecular formula of the green AIE molecule GAIE for preparing green AIE fluorescent microspheres is: 。 2. The ELISA detection method based on aggregation-induced emission ratio fluorescent probe according to claim 1, characterized in that: The ELISA detection method comprises the following steps: 1) Coating: Dilute the target antibody and streptavidin or digoxigenin complete antigen to 1 μg / mL with CBS 9.6 and add 100 μL to each well. Coat the plate overnight at 4°C and wash the plate three times with PBST. 2) Blocking: Block each well with 300 μL 0.2% gelatin CBS9.6 at 37°C for 2 h, then wash the plate three times with PBST; 3) Capture target antigen: 50 μL PBS 7.4 per well for negative and 50 μL target antigen per well for positive, then add 50 μL red AIE microsphere-coupled antigen or labeled antibody and green AIE microsphere-coupled biotin or digoxigenin antibody, react at 37°C for 30 min, and wash the plate three times with PBST; 4) Reading value: Green AIE fluorescent microspheres coupled with biotin and coated streptavidin or digoxigenin antibody and digoxigenin antigen combine to emit green fluorescence at 501 nm, and the reading value is recorded as G; after adding the target antigen or labeled antibody coupled with the analyte and red AIE fluorescent microspheres, the antigen and antibody specifically bind to each other and emit red fluorescence at 610 nm, and the reading value is recorded as R; For direct competitive ELISA, as the number of targets increases, the red fluorescence R value becomes lower and the R / G value becomes lower; for double antibody sandwich ELISA, as the number of targets increases, the red fluorescence R value becomes higher and the R / G value becomes higher.

3. The ELISA detection method based on aggregation-induced emission ratio fluorescent probe according to claim 1, characterized in that: The particle sizes of the RAIENPs and GAIENPs are 150 nm±5% and 350 nm±5%, respectively.